Celldex Therapeutics, Inc. Restructuring Charges
Celldex Therapeutics, Inc. (CLDX) reported Restructuring Charges of $400.00 thousand for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2018-08-08
- Celldex Therapeutics, Inc. restructuring charges for the quarter ending 2018-06-30 was $400.00K.
| Period end | Restructuring Charges 3 month | Restructuring Charges 9 month |
|---|---|---|
| 2018-06-30 | $400.00K 10-Q · filed 2018-08-08 | |
| 2017-09-30 | $170.00K 10-Q · filed 2017-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |